Decoy Biosystems’ Merger Agreement with Intec Pharma

Sheppard Mullin advised Decoy Biosystems , Inc. on the deal.Decoy Biosystems, Inc., a privately held, preclinical-stage biotechnology company developing novel, multi-targeted products that safely prime both…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now